US Global Invstr SEC Filings

The Vanguard Group filed an amendment (Schedule 13G/A) reporting zero beneficial ownership of US Global Investors Inc. common stock. The amendment states that following an internal realignment effective January 12, 2026, certain Vanguard subsidiaries will report holdings separately and The Vanguard Group no longer is deemed to beneficially own those securities. The filing lists 0 shares and 0% ownership and is signed by Ashley Grim, Head of Global Fund Administration on 03/27/2026.

U.S. Global Investors CEO/CIO Frank E. Holmes reported an employee stock purchase plan transaction in Class A common stock. On February 27, 2026, he acquired 716 shares at $3.33 per share through a restricted stock purchase under the plan, bringing his direct holdings to 298,250 shares. Indirectly, he reported 32,862 shares held in an IRA and 221,656.77 shares held in a 401(k) account.

U S Global Investors CFO Lisa Callicotte reported an “other” stock transaction involving company shares. On the reported date, a restricted stock purchase under the employee stock purchase plan covered 284 shares of Class A Common Stock at $3.33 per share. After this plan-related transaction, her directly held position in Class A Common Stock stood at 37,185 shares.

U.S. Global Investors, Inc. reported mixed second-quarter fiscal 2026 results for the period ended December 31, 2025. Total assets under management were about $1.5 billion, up 12% from the prior quarter and 5% from a year earlier, and had increased further to $1.7 billion by February 19.

Operating revenue rose to $2.51 million, an increase of $259,000, or 11.5%, from the prior quarter, while operating expenses fell versus the year-ago quarter. Income before taxes improved to $535,000 from a loss of $116,000 in the prior-year period.

Results were weighed down by a $1.38 million income tax expense tied to the tax treatment of certain HIVE Digital Technologies convertible securities, including a non-cash valuation allowance of approximately $471,000. Management expects an offsetting $1.3 million tax benefit in the quarter ending March 31, 2026, subject to IRS review, leading to a net loss of $846,000, or $(0.07) per share.

The company highlighted shareholder return efforts, citing a 9.89% shareholder yield as of December 31, 2025, a monthly dividend of $0.0075 per share authorized through March 2026, and repurchase of 262,195 shares during the quarter. Liquidity remained solid with net working capital of about $36.7 million and cash and cash equivalents of roughly $25.2 million.

U.S. Global Investors, Inc. reported modest profitability for the six months ended December 31, 2025, with net income of $661,000, up from $229,000 a year earlier, as stronger investment gains offset an operating loss.

Operating revenues rose to $4.8 million from $4.4 million, but the core investment management segment still posted an operating loss of $603,000. Net investment income improved to $2.8 million, driven by market gains on trading securities and other investments.

Results were volatile quarter to quarter: the December 2025 quarter showed a net loss of $846,000, largely due to $1.3 million of tax expense tied to HIVE convertible securities and a valuation allowance on capital loss carryforwards. The remaining HIVE debentures were paid off in December, realizing previously recorded losses.

The balance sheet remains conservative, with total assets of $47.2 million, including $26.2 million in cash, cash equivalents, and restricted cash, and low debt. The company continued returning capital, paying monthly dividends of $0.0075 per share and repurchasing 421,269 Class A shares for about $1.1 million in the six-month period.

Subsequent to December 31, 2025, the company recognized an additional unrealized gain of approximately $1.9 million on an equity investment and filed a tax accounting method change it expects will yield a tax benefit in the quarter ending March 31, 2026.

U.S. Global Investors, Inc. notified the SEC it cannot timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025 because it will file a tax accounting method change using Form 3115 related to convertible securities of HIVE purchased in January 2021.

The company expects to file the Quarterly Report within the five-calendar-day extension provided by Rule 12b-25 and expects to record a $1.3 million tax expense, including a $471,000 valuation allowance affecting results for the period ended December 31, 2025. The company expects an offsetting benefit and a reduction of the valuation allowance in the period ending March 31, 2026.

U.S. Global Investors CEO/CIO Frank E. Holmes, a director and more than 10% owner of GROW, reported buying 719 shares of Class A common stock on January 30, 2026 at $3.32 per share. This was a restricted stock purchase under an employee stock purchase plan.

After this transaction, Holmes directly owned 297,534 Class A shares, with additional indirect holdings of 32,862 shares in an IRA and 221,656.77 shares in a 401(k) account.

U.S. Global Investors CFO Lisa Callicotte reported a small share purchase in a Form 4 filing. On January 30, 2026, she acquired 285 shares of Class A common stock at $3.32 per share through a restricted stock purchase under the company’s employee stock purchase plan. Following this transaction, she directly owns 36,901 Class A shares. This reflects routine insider participation in an employee stock purchase program rather than a large discretionary trade.

U S Global Investors filed a Form 13F reporting institutional holdings totaling $933,957,324 across 158 entries. The report, signed by Lisa Callicotte, CFO, was executed in San Antonio, TX on 01-28-2026.

The Form 13F cover page shows this is a 13F holdings report and indicates no other included managers. The filing value is rounded to the nearest dollar as presented.